A new urine-based test improved prostate cancer detection – including detecting more aggressive forms of prostate cancer – compared to traditional models based on prostate serum antigen, or PSA, levels, a new study finds.
Prostate cancer specialists at the University of Michigan Comprehensive Cancer Center are refining prostate cancer diagnosis to better identify those cancers that are more likely to grow quickly and spread to other parts of the body.
The University of Michigan Health System has begun offering a new urine test called Mi-Prostate Score to improve on PSA screening for prostate cancer. The test incorporates three specific markers that could indicate cancer and studies have shown that the combination is far more accurate than PSA alone.
There are certain chronic conditions for which urology practices are better equipped to carry out medical home functions compared to their primary care counterparts, according to a new study led by researchers from the U-M.
Outpatient urological surgery costs significantly less when performed in physician offices and ambulatory care centers. But results may reflect the lower cost of treating patients who are less seriously ill.
A new study preports that in the “PSA era,” survival has improved for patients with newly diagnosed prostate cancer that has spread to the bones or other parts of the body and the disparity between African American and Caucasian men has been resolved.
The University of Michigan's C.S. Mott Children's Hospital is among the best children's hospitals and is the only hospital in Michigan ranked in all 10 specialties evaluated, according to the U.S. News & World Report's 2012-13 Best Children's Hospitals rankings.
The University of Michigan's C.S. Mott Children's Hospital has earned the highest rankings in the state of Michigan and is among the best in the country in pediatric specialties according to the U.S. News Media Group's Best Children's Hospital rankings.